Dianthus Therapeutics, Inc. (DNTH) vs Iovance Biotherapeutics, Inc. (IOVA)
Dianthus Therapeutics, Inc. and Iovance Biotherapeutics, Inc. are both Biotechnology companies. Dianthus Therapeutics, Inc. and Iovance Biotherapeutics, Inc. are of similar size ($5.1B and $4.9B). Iovance Biotherapeutics, Inc. grew revenue faster over the last twelve months: 34.6% against −60.8%. Iovance Biotherapeutics, Inc. has the higher net margin (−89.1% vs −10,097.0%) and the higher return on invested capital (−43.0% vs −47.7%). Across the 16 metrics below, Iovance Biotherapeutics, Inc. leads on 9 and Dianthus Therapeutics, Inc. on 7.
Valuation
Profitability
| Metric | DNTH | IOVA | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 48.40% | 65.16% |
| Operating margin | (11,441.39%) | (92.72%) | 0.00% |
| Net margin | (10,096.95%) | (89.09%) | 0.00% |
| Free cash flow margin | (8,177.99%) | (91.21%) | 0.00% |
| Return on equity | (26.07%) | (40.36%) | (57.72%) |
| Return on assets | (24.98%) | (31.76%) | (49.22%) |
| Return on invested capital | (47.74%) | (42.96%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack